AAAAAA

   
Results: 1-16 |
Results: 16
CLINICAL-PRACTICE GUIDELINES - PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER RENAL-TRANSPLANTATION
Authors: JASSAL SV ROSCOE JM ZALTZMAN JS MAZZULLI T KRAJDEN M GADAWSKI M CATTRAN DC CARDELLA CJ ALBERT SE COLE EH
Citation: Sv. Jassal et al., CLINICAL-PRACTICE GUIDELINES - PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER RENAL-TRANSPLANTATION, Journal of the American Society of Nephrology, 9(9), 1998, pp. 1697-1708
ARE ALL PATIENTS WITH IDIOPATHIC FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) CREATED EQUAL
Authors: CATTRAN DC
Citation: Dc. Cattran, ARE ALL PATIENTS WITH IDIOPATHIC FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) CREATED EQUAL, Nephrology, dialysis, transplantation, 13(5), 1998, pp. 1107-1109
LONG-TERM OUTCOME IN CHILDREN AND ADULTS WITH CLASSIC FOCAL SEGMENTALGLOMERULOSCLEROSIS
Authors: CATTRAN DC RAO P
Citation: Dc. Cattran et P. Rao, LONG-TERM OUTCOME IN CHILDREN AND ADULTS WITH CLASSIC FOCAL SEGMENTALGLOMERULOSCLEROSIS, American journal of kidney diseases, 32(1), 1998, pp. 72-79
EVALUATION OF THE PLASMA PERMEABILITY ACTIVITY (P-ALB) IN STEROID-RESISTANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Authors: CATTRAN DC APPEL G HEBERT L POHL M MCCARTHY ET SHARMA R BUTCHER J SAVIN VJ
Citation: Dc. Cattran et al., EVALUATION OF THE PLASMA PERMEABILITY ACTIVITY (P-ALB) IN STEROID-RESISTANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS), Journal of the American Society of Nephrology, 8, 1997, pp. 398-398
IMPACT OF GENDER ON RENAL-FUNCTION AND THE RESPONSE TO ANGIOTENSIN-II(ANGII)
Authors: MILLER JA ANACTA LA CATTRAN DC
Citation: Ja. Miller et al., IMPACT OF GENDER ON RENAL-FUNCTION AND THE RESPONSE TO ANGIOTENSIN-II(ANGII), Journal of the American Society of Nephrology, 8, 1997, pp. 1612-1612
PREVALENCE AND SIGNIFICANCE OF HYPERCHOLESTEROLEMIA AFTER RENAL-TRANSPLANTATION
Authors: KARPINSKI J CATTRAN DC
Citation: J. Karpinski et Dc. Cattran, PREVALENCE AND SIGNIFICANCE OF HYPERCHOLESTEROLEMIA AFTER RENAL-TRANSPLANTATION, Journal of the American Society of Nephrology, 8, 1997, pp. 3321-3321
IDIOPATHIC MEMBRANOUS NEPHROPATHY IN THE ELDERLY - A COMPARATIVE-STUDY
Authors: ZENT R NAGAI R CATTRAN DC
Citation: R. Zent et al., IDIOPATHIC MEMBRANOUS NEPHROPATHY IN THE ELDERLY - A COMPARATIVE-STUDY, American journal of kidney diseases, 29(2), 1997, pp. 200-206
VALIDATION OF A PREDICTIVE MODEL OF IDIOPATHIC MEMBRANOUS NEPHROPATHY- ITS CLINICAL AND RESEARCH IMPLICATIONS
Authors: CATTRAN DC PEI Y GREENWOOD CMT PONTICELLI C PASSERINI P HONKANEN E
Citation: Dc. Cattran et al., VALIDATION OF A PREDICTIVE MODEL OF IDIOPATHIC MEMBRANOUS NEPHROPATHY- ITS CLINICAL AND RESEARCH IMPLICATIONS, Kidney international, 51(3), 1997, pp. 901-907
ACCURATE MEASUREMENT OF IMPAIRED GLOMERULAR-FILTRATION USING SINGLE-DOSE ORAL CIMETIDINE
Authors: ZALTZMAN JS WHITESIDE C CATTRAN DC LOPEZ FM LOGAN AG
Citation: Js. Zaltzman et al., ACCURATE MEASUREMENT OF IMPAIRED GLOMERULAR-FILTRATION USING SINGLE-DOSE ORAL CIMETIDINE, American journal of kidney diseases, 27(4), 1996, pp. 504-511
A CONTROLLED TRIAL OF CYCLOSPORINE IN PATIENTS WITH PROGRESSIVE MEMBRANOUS NEPHROPATHY
Authors: CATTRAN DC GREENWOOD C RITCHIE S BERNSTEIN K CHURCHILL DN CLARK WF MORRIN PA LAVOIE S
Citation: Dc. Cattran et al., A CONTROLLED TRIAL OF CYCLOSPORINE IN PATIENTS WITH PROGRESSIVE MEMBRANOUS NEPHROPATHY, Kidney international, 47(4), 1995, pp. 1130-1135
IMMUNOLOGICAL ASPECTS OF GLOMERULAR-DISEASES OF THE KIDNEY - PATHOGENESIS AND TREATMENT
Authors: CATTRAN DC
Citation: Dc. Cattran, IMMUNOLOGICAL ASPECTS OF GLOMERULAR-DISEASES OF THE KIDNEY - PATHOGENESIS AND TREATMENT, CLINICAL IMMUNOTHERAPEUTICS, 2(5), 1994, pp. 390-406
SAFETY AND EFFICACY OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CORRECTINGTHE ANEMIA OF PATIENTS WITH CHRONIC RENAL-ALLOGRAFT DYSFUNCTION
Authors: MUIRHEAD N CATTRAN DC ZALTZMAN J JINDAL K FIRST MR BOUCHER A KEOWN PA MUNCH LC WONG C
Citation: N. Muirhead et al., SAFETY AND EFFICACY OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CORRECTINGTHE ANEMIA OF PATIENTS WITH CHRONIC RENAL-ALLOGRAFT DYSFUNCTION, Journal of the American Society of Nephrology, 5(5), 1994, pp. 1216-1222
STEROID-THERAPY AND PROGNOSIS OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN THE ELDERLY
Authors: NAGAI R CATTRAN DC PEI Y
Citation: R. Nagai et al., STEROID-THERAPY AND PROGNOSIS OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN THE ELDERLY, Clinical nephrology, 42(1), 1994, pp. 18-21
LONG-TERM BENEFITS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPYIN PATIENTS WITH SEVERE IMMUNOGLOBULIN A NEPHROPATHY - A COMPARISON TO PATIENTS RECEIVING TREATMENT WITH OTHER ANTIHYPERTENSIVE AGENTS AND TO PATIENTS RECEIVING NO THERAPY
Authors: CATTRAN DC GREENWOOD C RITCHIE S
Citation: Dc. Cattran et al., LONG-TERM BENEFITS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPYIN PATIENTS WITH SEVERE IMMUNOGLOBULIN A NEPHROPATHY - A COMPARISON TO PATIENTS RECEIVING TREATMENT WITH OTHER ANTIHYPERTENSIVE AGENTS AND TO PATIENTS RECEIVING NO THERAPY, American journal of kidney diseases, 23(2), 1994, pp. 247-254
A COMPARISON OF RABBIT ANTITHYMOCYTE-SERUM AND OKT3 AS PROPHYLAXIS AGAINST RENAL-ALLOGRAFT REJECTION
Authors: COLE EH CATTRAN DC FAREWELL VT APRILE M BEAR RA PEI YP FENTON SS TOBER JAL CARDELLA CJ
Citation: Eh. Cole et al., A COMPARISON OF RABBIT ANTITHYMOCYTE-SERUM AND OKT3 AS PROPHYLAXIS AGAINST RENAL-ALLOGRAFT REJECTION, Transplantation, 57(1), 1994, pp. 60-67
CONTEMPORARY MANAGEMENT OF RENAL-FAILURE - OUTCOME OF THE FAILED ALLOGRAFT RECIPIENT
Authors: CATTRAN DC FENTON SSA
Citation: Dc. Cattran et Ssa. Fenton, CONTEMPORARY MANAGEMENT OF RENAL-FAILURE - OUTCOME OF THE FAILED ALLOGRAFT RECIPIENT, Kidney international, 43, 1993, pp. 36-39
Risultati: 1-16 |